Rosuvastatin Stada 5 mg

Rosuvastatin Stada 5 mg is a medicine authorised by Swissmedic under authorisation number 66606. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 May 2017 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category B
  • Authorisation number 66606
  • Synthetic medicines
Authorisation data
Authorisation number66606
NameRosuvastatin Stada 5 mg
Full nameRosuvastatin Stada 5 mg, Filmtabletten
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codenot stated
First authorisation31 May 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Rosuvastatin Stada 5 mg, FilmtablettenB31 May 2017
2Rosuvastatin Stada 10 mg, FilmtablettenB31 May 2017
3Rosuvastatin Stada 20 mg, FilmtablettenB31 May 2017
4Rosuvastatin Stada 40 mg, FilmtablettenB31 May 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Rosuvastatin Stada 5 mg authorised in Switzerland?

Yes. Rosuvastatin Stada 5 mg is authorised by Swissmedic under authorisation number 66606, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Rosuvastatin Stada 5 mg have?

Rosuvastatin Stada 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rosuvastatin Stada 5 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com